“…Compared with unsubstituted and monosubstituted (R 2 position) 4‐quinolones 33a–h (IC 50 : 0.410–2.300 µM) (Figure ), the bis‐substituted analogs 33i–q (IC 50 : 0.026–0.370 µM) displayed higher inhibitory activity against IN ST . In general, the derivatives 33l–q (EC 50 : 0.290–2.340 µM and IC 50 : 0.026–0.083 µM) with alkyl at N‐1 position were more potent than the unsubstituted 33k (EC 50 : 3.400 µM and IC 50 : 0.026–0.070 µM) against HIV‐1 and IN ST, suggesting the substituents at N‐1 position had great influence on the activity. Further study indicated that incorporation of acids ( 34a,b ) or amides ( 34c,d ) or aminoethylene ( 34e ) could not improve the activity, while hydroxyalkyl ( 34f,g ) was favorable to the activity (Figure ) .…”